THX Pharma
ALTHX.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | €1 | €1 | €2 | €6 |
| Short-Term Investments | €0 | €4 | €7 | €7 |
| Receivables | €1 | €0 | €0 | €0 |
| Inventory | €0 | €0 | €0 | €0 |
| Other Curr. Assets | €1 | €1 | €1 | €2 |
| Total Curr. Assets | €3 | €6 | €11 | €15 |
| Property Plant & Equip (Net) | €0 | €0 | €0 | €0 |
| Goodwill | €0 | €0 | €0 | €0 |
| Intangibles | €1 | €1 | €1 | €1 |
| Long-Term Investments | €0 | €0 | €0 | €0 |
| Tax Assets | €0 | €0 | €0 | €0 |
| Other NC Assets | €0 | €0 | €0 | €0 |
| Total NC Assets | €1 | €1 | €2 | €2 |
| Other Assets | €0 | €0 | €0 | €0 |
| Total Assets | €4 | €7 | €12 | €17 |
| Liabilities | – | – | – | – |
| Payables | €1 | €1 | €1 | €1 |
| Short-Term Debt | €1 | €1 | €1 | €1 |
| Tax Payable | €0 | €0 | €1 | €0 |
| Deferred Revenue | €0 | €0 | -€1 | -€1 |
| Other Curr. Liab. | €2 | €0 | €1 | €0 |
| Total Curr. Liab. | €4 | €3 | €3 | €1 |
| LT Debt | €2 | €2 | €4 | €5 |
| Deferred Rev, NC | €0 | €0 | €0 | €0 |
| Deferred Tax Liab, NC | €0 | €0 | €0 | €0 |
| Other NC Liab. | €0 | €0 | €0 | €0 |
| Total NC Liab. | €2 | €2 | €4 | €5 |
| Other Liabilities | €0 | €0 | €0 | €0 |
| Cap. Leases | €0 | €0 | €0 | €0 |
| Total Liabilities | €5 | €5 | €6 | €7 |
| Equity | – | – | – | – |
| Pref Stock | €0 | €5 | €0 | €7 |
| Common Stock | €2 | €2 | €1 | €1 |
| Retained Earnings | -€2 | -€7 | -€7 | -€8 |
| AOCI | €0 | -€7 | €3 | -€8 |
| Other Equity | -€2 | €7 | €8 | €17 |
| Total Equity | -€2 | €2 | €6 | €10 |
| Supplemental Information | – | – | – | – |
| Minority Interest | €0 | €0 | €0 | €0 |
| Total Liab. & Tot. Equity | €4 | €7 | €12 | €17 |
| Net Debt | €2 | €2 | €3 | €1 |